KR100817264B1 - 구제역 바이러스 3ab 비구조단백질과 이에 특이적으로반응하는 단일클론 항체 및 이들의 조합을 이용한 구제역바이러스의 비구조단백질 항체 검사 또는 구제역의 진단방법 - Google Patents
구제역 바이러스 3ab 비구조단백질과 이에 특이적으로반응하는 단일클론 항체 및 이들의 조합을 이용한 구제역바이러스의 비구조단백질 항체 검사 또는 구제역의 진단방법 Download PDFInfo
- Publication number
- KR100817264B1 KR100817264B1 KR1020050103057A KR20050103057A KR100817264B1 KR 100817264 B1 KR100817264 B1 KR 100817264B1 KR 1020050103057 A KR1020050103057 A KR 1020050103057A KR 20050103057 A KR20050103057 A KR 20050103057A KR 100817264 B1 KR100817264 B1 KR 100817264B1
- Authority
- KR
- South Korea
- Prior art keywords
- foot
- protein
- mouth
- virus
- monoclonal antibody
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 56
- 241000710198 Foot-and-mouth disease virus Species 0.000 title claims abstract description 45
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 31
- 241001465754 Metazoa Species 0.000 title description 14
- 238000011895 specific detection Methods 0.000 title 1
- 241000700605 Viruses Species 0.000 claims abstract description 68
- 102000036639 antigens Human genes 0.000 claims abstract description 26
- 108091007433 antigens Proteins 0.000 claims abstract description 26
- 239000000427 antigen Substances 0.000 claims abstract description 22
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 claims abstract description 21
- 101710172711 Structural protein Proteins 0.000 claims abstract description 20
- 238000012360 testing method Methods 0.000 claims abstract description 19
- 238000002405 diagnostic procedure Methods 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 238000003745 diagnosis Methods 0.000 claims description 6
- 210000004408 hybridoma Anatomy 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 238000009007 Diagnostic Kit Methods 0.000 claims description 3
- 239000012472 biological sample Substances 0.000 claims description 2
- 238000002965 ELISA Methods 0.000 abstract description 16
- 241000588724 Escherichia coli Species 0.000 abstract description 13
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 12
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 12
- 208000015181 infectious disease Diseases 0.000 abstract description 11
- 230000009257 reactivity Effects 0.000 abstract description 9
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 238000001514 detection method Methods 0.000 abstract description 6
- 230000000903 blocking effect Effects 0.000 abstract description 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 5
- 230000002860 competitive effect Effects 0.000 abstract description 4
- 238000003018 immunoassay Methods 0.000 abstract description 4
- 244000144972 livestock Species 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000009385 viral infection Effects 0.000 abstract description 3
- 101710188642 Non-structural protein 3b Proteins 0.000 abstract description 2
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 22
- 229960005486 vaccine Drugs 0.000 description 19
- 239000000523 sample Substances 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 9
- 238000002255 vaccination Methods 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 206010029719 Nonspecific reaction Diseases 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 241000709710 Swine vesicular disease virus Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000004754 hybrid cell Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 101710091045 Envelope protein Proteins 0.000 description 2
- 102100034349 Integrase Human genes 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 101710188315 Protein X Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000004779 membrane envelope Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100031974 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Human genes 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 102100034274 Diamine acetyltransferase 1 Human genes 0.000 description 1
- 102100028999 High mobility group protein HMGI-C Human genes 0.000 description 1
- 101000703754 Homo sapiens CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Proteins 0.000 description 1
- 101000641077 Homo sapiens Diamine acetyltransferase 1 Proteins 0.000 description 1
- 101000986379 Homo sapiens High mobility group protein HMGI-C Proteins 0.000 description 1
- 101000713305 Homo sapiens Sodium-coupled neutral amino acid transporter 1 Proteins 0.000 description 1
- 101000640813 Homo sapiens Sodium-coupled neutral amino acid transporter 2 Proteins 0.000 description 1
- 101000716973 Homo sapiens Thialysine N-epsilon-acetyltransferase Proteins 0.000 description 1
- 102000018297 Immunoglobulin subtype Human genes 0.000 description 1
- 108050007411 Immunoglobulin subtype Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- XEQLGWAGMYUVTR-UHFFFAOYSA-N O=C1NC=NC2=C1NC=N2.C1=CN=C2C(=O)NC(NN)=NC2=N1 Chemical compound O=C1NC=NC2=C1NC=N2.C1=CN=C2C(=O)NC(NN)=NC2=N1 XEQLGWAGMYUVTR-UHFFFAOYSA-N 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 102100020926 Thialysine N-epsilon-acetyltransferase Human genes 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009933 burial Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000011330 nucleic acid test Methods 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000005892 protein maturation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1009—Picornaviridae, e.g. hepatitis A virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
- G01N2333/09—Foot-and-mouth disease virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (6)
- 기탁번호 KCTC 10848BP인 하이브리도마 세포주에 의해서 생산되고, 구제역 바이러스의 서열번호 2로 표시된 에피토프와 특이적으로 반응하는 단일클론 항체.
- 구제역 바이러스 3AB 단백질의 항원을 특이적으로 인식하는 제 1항 기재의 단일클론 항체를 사용하여 구제역 바이러스의 비구조단백질 항체 검사 또는 구제역의 진단 방법.
- 제 2 항에 있어서,상기 구제역 바이러스는 구제역 바이러스 분리주 O/SKR/2002(AY312589)인 것을 특징으로 하는 구제역 바이러스의 비구조단백질 항체 검사 또는 구제역의 진단 방법.
- 삭제
- 구제역 바이러스의 3AB 단백질과 제 1 항 기재의 단일클론 항체의 조합으로 구제역 바이러스의 비구조단백질 항체 검사 방법.
- 피검체로부터 채취한 생물학적 시료와 구제역 바이러스의 3AB 단백질 및 제 1 항 기재의 단일클론 항체를 반응시켜 항원-항체 반응을 검출하는 구제역 진단 키트.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050103057A KR100817264B1 (ko) | 2005-10-31 | 2005-10-31 | 구제역 바이러스 3ab 비구조단백질과 이에 특이적으로반응하는 단일클론 항체 및 이들의 조합을 이용한 구제역바이러스의 비구조단백질 항체 검사 또는 구제역의 진단방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050103057A KR100817264B1 (ko) | 2005-10-31 | 2005-10-31 | 구제역 바이러스 3ab 비구조단백질과 이에 특이적으로반응하는 단일클론 항체 및 이들의 조합을 이용한 구제역바이러스의 비구조단백질 항체 검사 또는 구제역의 진단방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070046390A KR20070046390A (ko) | 2007-05-03 |
KR100817264B1 true KR100817264B1 (ko) | 2008-03-27 |
Family
ID=38271748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050103057A KR100817264B1 (ko) | 2005-10-31 | 2005-10-31 | 구제역 바이러스 3ab 비구조단백질과 이에 특이적으로반응하는 단일클론 항체 및 이들의 조합을 이용한 구제역바이러스의 비구조단백질 항체 검사 또는 구제역의 진단방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100817264B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101412038B1 (ko) * | 2012-07-27 | 2014-07-01 | 대한민국 | C형 구제역 바이러스 유전자재조합 단백질 항원과 단클론항체를 이용한 c형 구제역 진단방법 |
KR101873204B1 (ko) * | 2016-12-12 | 2018-07-12 | 대한민국 | 구제역 바이러스 입자 판별 방법 |
KR102241521B1 (ko) * | 2019-04-15 | 2021-04-20 | 대한민국(농림축산식품부 농림축산검역본부장) | 구제역 바이러스 o형에 면역 반응성을 나타내는 항체를 이용한 구제역 백신 접종으로 생성된 항체를 검출하는 방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048538A (en) * | 1997-10-03 | 2000-04-11 | United Biomedical, Inc. | Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents |
KR20030052858A (ko) * | 2001-12-21 | 2003-06-27 | 대한민국(관리부서 : 농림부 국립수의과학검역원) | 곤충세포 발현 재조합 3abc 비구조단백질 항원 및단클론항체를 이용한 구제역 진단방법 |
KR20030052859A (ko) * | 2001-12-21 | 2003-06-27 | 대한민국(관리부서 : 농림부 국립수의과학검역원) | 재조합 구제역 2c 비구조단백질 항원 및 단클론항체를이용한 구제역 진단방법 |
KR20050082512A (ko) * | 2004-02-19 | 2005-08-24 | 대한민국(관리부서 농림부 국립수의과학검역원) | 구제역 바이러스의 2c 및 3b 비구조단백질에 대한펩타이드를 포함하는 구제역 진단용 키트 |
-
2005
- 2005-10-31 KR KR1020050103057A patent/KR100817264B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048538A (en) * | 1997-10-03 | 2000-04-11 | United Biomedical, Inc. | Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents |
KR20030052858A (ko) * | 2001-12-21 | 2003-06-27 | 대한민국(관리부서 : 농림부 국립수의과학검역원) | 곤충세포 발현 재조합 3abc 비구조단백질 항원 및단클론항체를 이용한 구제역 진단방법 |
KR20030052859A (ko) * | 2001-12-21 | 2003-06-27 | 대한민국(관리부서 : 농림부 국립수의과학검역원) | 재조합 구제역 2c 비구조단백질 항원 및 단클론항체를이용한 구제역 진단방법 |
KR20050082512A (ko) * | 2004-02-19 | 2005-08-24 | 대한민국(관리부서 농림부 국립수의과학검역원) | 구제역 바이러스의 2c 및 3b 비구조단백질에 대한펩타이드를 포함하는 구제역 진단용 키트 |
Non-Patent Citations (7)
Title |
---|
J. Clin. Microbiol., 40(8), 2843-2848(2002) |
J. General Virol., 84, 1583-1593(2003) |
Vaccine, 17, 3039-3049(1999) |
대한민국 공개특허 제10-2003-0052858호(2003.06.27.) |
대한민국 공개특허 제10-2003-0052859호(2003.06.27.) |
대한민국 공개특허 제10-2005-0082512호(2005.08.24.) |
미국등록특허 제6,048,538호(2000.04.11.) |
Also Published As
Publication number | Publication date |
---|---|
KR20070046390A (ko) | 2007-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hirota et al. | Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production | |
TWI392735B (zh) | 口蹄疫融合瘤細胞株、其單株抗體、及包含該單株抗體的elisa檢測試劑及套組 | |
US10035841B2 (en) | Monoclonal antibody against novel epitopes of foot-and-mouth disease virus protein 3ABC and uses thereof | |
Esterhuysen et al. | A liquid-phase blocking ELISA for the detection of antibodies to rabies virus | |
US10261092B2 (en) | Cross-reactive determinants and methods for their identification | |
Oem et al. | Development of synthetic peptide ELISA based on nonstructural protein 2C of foot and mouth disease virus. | |
HUE034632T2 (en) | Improved vaccine diagnostics | |
KR100817264B1 (ko) | 구제역 바이러스 3ab 비구조단백질과 이에 특이적으로반응하는 단일클론 항체 및 이들의 조합을 이용한 구제역바이러스의 비구조단백질 항체 검사 또는 구제역의 진단방법 | |
US7169393B2 (en) | Antigenic peptide fragments of VapA protein, and uses thereof | |
Gandhale et al. | Detection of bluetongue virus group-specific antigen using monoclonal antibody based sandwich ELISA | |
KR101102841B1 (ko) | 하이브리도마 세포주, 이에 의해 생산된 단클론항체,구제역 진단 시약, 진단 키트 및 구제역 바이러스 중화항체검출방법 | |
KR102450481B1 (ko) | 돼지열병 바이러스 특이적인 항체 및 이의 용도 | |
Kumar et al. | Production of monoclonal antibodies specific to major outer membrane protein of Edwardsiella tarda | |
WO2019245392A1 (es) | Kit diagnóstico diferencial y rápido para detección de la coriza infecciosa y el sindrome de cabeza hinchada en la industria avícola | |
CN116987184B (zh) | 新型冠状病毒bq.1.1突变株特异性抗体及其应用 | |
Mallick et al. | Production and characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and development of a sandwich ELISA for virus antigen detection | |
KR102614002B1 (ko) | 구제역 바이러스 a형에 면역반응성을 나타내는 항체, 이를 포함하는 구제역 바이러스 a형 항체 검출용 조성물, 및 이를 이용하는 구제역 바이러스 a형 항체를 검출하는 방법 | |
KR102241520B1 (ko) | 구제역 바이러스 o형에 면역반응성을 나타내는 항체 및 이를 포함하는 구제역 바이러스 검출용 조성물 | |
KR102241521B1 (ko) | 구제역 바이러스 o형에 면역 반응성을 나타내는 항체를 이용한 구제역 백신 접종으로 생성된 항체를 검출하는 방법 | |
CN116284363B (zh) | 新型冠状病毒OmicronBA.2/4/5突变株特异性抗体及其应用 | |
CN116874594B (zh) | 新型冠状病毒突变株xbb.1.5特异性抗体及其应用 | |
KR20040062218A (ko) | 돼지콜레라 바이러스에 대한 단일클론항체, 이를 생산하는하이브리도마 세포주, 및 단일클론항체를 이용한돼지콜레라 바이러스 검출법 | |
Cornaglia et al. | Detection of porcine respiratory coronavirus and transmissible gastroenteritis virus by an enzyme-linked immunosorbent assay | |
KR100430935B1 (ko) | 대장균 발현 재조합 3abc 비구조단백질 및단클론항체를 이용한 구제역 진단방법 | |
Bulashev et al. | Validation of a chimeric proteins-based ELISA for the diagnosis of brucellosis in Kazakhstan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130122 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140124 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150305 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170316 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190227 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20200227 Year of fee payment: 13 |